Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 6NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia 26Lymphoma, Large B-Cell, Diffuse 22Breast Neoplasms 21Lymphoma, Follicular 18Leukemia, Myeloid, Acute 18Burkitt Lymphoma 16Multiple Myeloma 15Lymphoma, Non-Hodgkin 15Lymphoma, Mantle-Cell 14Leukemia, Lymphocytic, Chronic, B-Cell 13Hodgkin Disease 13Lymphoma, Large-Cell, Immunoblastic 12Neuroblastoma 11Melanoma 11Myelodysplastic Syndromes 10Lymphoma, B-Cell, Marginal Zone 10Neoplasms, Plasma Cell 9Sarcoma 8Leukemia, Myeloid, Chronic-Phase 8Neutropenia 7Central Nervous System Neoplasms 7Myeloproliferative Disorders 6Medulloblastoma 6Leukemia, Myelomonocytic, Acute 6Congenital Abnormalities 6Waldenstrom Macroglobulinemia 5Neoplasms 5Leukemia, Myelomonocytic, Chronic 5

Interventions

Temozolomide 5O(6)-benzylguanine 3Vorinostat 2Radiotherapy 2Oxaliplatin 2Lenalidomide 2Cilengitide 2Carboplatin 2veliparib 1tipifarnib 1romidepsin 1pomalidomide 1pazopanib 1ixabepilone 1ispinesib 1cediranib 1becatecarin 1alvocidib 1Verteporfin 1Tamoxifen 1RMP 7 1PT-100 dipeptide 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Gelclair 1Filgrastim 1Erlotinib Hydrochloride 1Doxorubicin 1Dexamethasone 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Optic Nerve Glioma × Filgrastim × Clear all
NCT00052780 2013-09-30

Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors

National Cancer Institute (NCI)

Phase 1 Completed
72 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Oligodendroglioma, Choroid Plexus Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡